Sun, 19 July 2015
Liquid biopsies (also called serum testing) is a practice already approved in Europe for EGFR lung cancer patients. Drawing blood to test for acquired resistance is easier and quicker than needle biopsies. How long until it is standard practice in the US?
Direct download: GRACEcast-344_ASCO_2015_Liquid_Biopsies_Faster_Results_Easier_Patients.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT